Green tea polyphenol (-)-epigallocatechin gallate suppressed the differentiation of murine osteoblastic MC3T3-E1 cells

Cell Biology International

Volumn 34, Issue 1, 2010, Pages 109-116

  Kamon, Masayoshi ^a   Zhao, Ran ^a   Sakamoto, Kazuichi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Catechin; Osteoblast; Polyphenol

Indexed keywords

ACETYLCYSTEINE; ALKALINE PHOSPHATASE; EPIGALLOCATECHIN GALLATE; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; POLYPHENOL; RESVERATROL; CATECHIN; DRUG DERIVATIVE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE METABOLISM; BONE MINERALIZATION; CALVARIA; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; MALE; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; TEA; ANIMAL; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECT;

MURINAE;

ANIMALS; BONE MARROW CELLS; CATECHIN; CELL DIFFERENTIATION; CELL LINE; COCULTURE TECHNIQUES; MICE; OSTEOBLASTS; TEA;

EID: 77951930977     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20090011     Document Type: Article

References (38)

1. Amano H, Yamada S, Felix R. Colony-stimulating factor-1 stimulates the fusion process in osteoclasts. J Bone Miner Res 1998;13:846-53.
2. Boissy P, Andersen TL, Abdallah BM, Kassem M, Plesner T, Delaissé JM. Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation. Cancer Res 2005;65:9943-52.
3. Chang JK, Hsu YL, Teng IC, Kuo PL. Piceatannol stimulates osteoblast differentiation that may be mediated by increased bone morphogenetic protein-2 production. Eur J Pharmacol 2006; 551:1-9.
4. Chen D, Milacic V, Chen MS, Wan SB, Lam WH, Huo C et al. Tea polyphenols, their biological effects and potential molecular targets. Histol Histopathol 2008;23:487-96.
5. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
6. Crespy V and Williamson G. A review of the health effects of green tea catechins in in vivo animal models. J Nutr 2004;134:3431S-40S.
7. Fujiwara Y, Yamada K, Tachibana H. A lipid raft-associated 67 kDa laminin receptor mediates suppressive effect of epigallocatechin-3-O-gallate on FcepsilonRI expression. Biochem Biophys Res Commun 2005;336:674-81.
8. Hegarty VM, May HM, Khaw KT. Tea drinking and bone mineral density in older women. Am J Clin Nutr 2000;71:1003-7.
9. Ishida N, Hayashi K, Hoshijima M, Ogawa T, Koga S, Miyatake Y et al. Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J Biol Chem 2002;277:41147-56.
10. Jimi E, Nakamura I, Amano H, Taguchi Y, Tsurukai T, Tamura M et al. Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact. Endocrinology 1996;137:2187-90.
11. Jun JH, Lee SH, Kwak HB, Lee ZH, Seo SB, Woo KM et al. N-Acetylcysteine stimulates osteoblastic differentiation of mouse calvarial cells. J Cell Biochem 2008;103:1246-55.
12. Katagiri T, Takahashi N. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 2002;8:147-59.
13. Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res 2006;66:2500-5.
14. Kodaira K, Imada M, Goto M, Tomoyasu A, Fukuda T, Kamijo R et al. Purification and identification of a BMP-like factor from bovine serum. Biochem Biophys Res Commun 2006;345:1224-31.
15. Kodama H, Amagai Y, Sudo S. Establishment of aclonal osteogenic cell line from newborn mouse calvaria. Jpn J Oral Biol 1981;23:899-901.
16. Komori T. Regulation of skeletal development by the Runx family of transcription factors. J Cell Biochem 2005;95:445-53.
17. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-76.
18. Matsumoto M, Sudo T, Maruyama M, Osada H, Tsujimoto M. Activation of p38 mitogen-activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor. FEBS Lett 2000;486:23-8.
19. McKay DL, Blumberg JB. The role of tea in human health: an update. J Am Coll Nutr 2002;21:1-13.
20. Meiyanto E, Hoshijima M, Ogawa T, et al. Osteoclast differentiation factor modulates cell cycle machinery and causes a delay in S phase progression in RAW264 cells. Biochem Biophys Res Commun 2001;282:278-83.
21. Mizutani K, Ikeda K, Kawai Y, Yamori Y. Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun 1998;253:859-63.
22. Nagal DG, Ferreira D, Zhou YD. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives. Phytochemistry 2006;67:1849-55.
23. Nakagawa H, Wachi M, Woo JT, Kato M, Kasai S, Takahashi F et al. Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin-3-gallate to induce osteoclastic cell death. Biochem Biophys Res Commun 2002;292:94-101.
24. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B. The novel zinc finger-containing transcriptionc factor osterix is required for osteoblast differentiation and bone formation. Cell 2002;108:17-29.
25. Ralph P, Nakoinz, I. Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPS. J Immunol 1977;119:950-4.
26. Saika M, Inoue D, Kido S, Matsumoto T. 17 beta-estradiol stimulates expression of osteoprotegerin by a mouse stromal cell line, ST-2, via estrogen receptor-alpha. Endocrinology 2001;142:2205-12.
27. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999;20:345-57.
28. Tachibana H, Koga K, Fujimura Y, Yamada K. A receptor for green tea polyphenol EGCG. Nat Struct Mol Biol 2004;11:380-1.
29. Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM et al. Osteoblastic cells are involved in osteoclast formation. Endocrinology 1988;123:2600-2.
30. Takita H, Kikuchi M, Sato Y, Kuboki Y. Inhibition of BMP-induced ectopic bone formation by an antiangiogenic agent (epigallocatechin 3-gallate). Connect Tissue Res 2002;43:520-3.
31. Ullmann U, Haller J, Decourt JP, Girault N, Girault J, Richard-Caudron AS et al. A single ascending dose study of epigallocatechin gallate in healthy volunteers. J Int Med Res 2003;31:88-101.
32. Umeda D, Tachibana H, Yamada K. Epigallocatechin-3-O-gallate disrupts stress fibres and the contractile ring by reducing myosin regulatory light chain phosphorylation mediated through the target molecule 67 kDa laminin receptor. Biochem Biophys Res Commun 2005;333:628-35.
33. Vali H, Rao LG, El-Sohemy A. Epigallocatechin-3-gallate increases the formation of mineralized bone nodules by human osteoblast-like cells. J Nutr Biochem 2007;18:341-7.
34. Wang J, Shang F, Jiang R, Liu L, Wang S, Hou J et al. Nitric oxidedonating genistein prodrug: design, synthesis, and bioactivity on MC3T3-E1 cells. J Pharmacol Sci 2007;104:82-9.
35. Yanai H. Statcel: the useful add-in software forms on Excel (2nd ed). Saitama, Japan: OMS; 2004.
36. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998;95:3597-602.
37. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990;345: 442-4.
38. Yun JH, Kim CS, Cho KS, Chai JK, Kim CK, Choi SH. (-)-Epigallocatechin gallate induces apoptosis, via caspase activation, in osteoclasts differentiated from RAW 264.7 cells. J Periodontal Res 2007;42:212-8.